Back
NeoGenomics Vs. Panbela Therapeutics Industry Stock Comparison
Sell
44
NEO
NeoGenomics
Last Price:
$7.01
Seasonality Move:
11.35%
Sell
1
PBLA
Panbela Therapeutics
Last Price:
$0.25
Seasonality Move:
-15.41%
Sell
44
NeoGenomics (NEO)
is a Sell
Is NeoGenomics a Buy, Sell or Hold?
-
The current NeoGenomics [NEO] share price is $7.00. The Score for NEO is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
-
NEO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
1
Panbela Therapeutics (PBLA)
is a Sell
Is Panbela Therapeutics a Buy, Sell or Hold?
-
The current Panbela Therapeutics [PBLA] share price is $0.23. The Score for PBLA is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
-
PBLA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
NEO Stock Price Chart
What is NeoGenomics's stock price today?
-
The NeoGenomics share price today is $7.00Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NEO is experiencing slight selling pressure.
PBLA Stock Price Chart
What is Panbela Therapeutics's stock price today?
-
The Panbela Therapeutics share price today is $0.23Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PBLA is experiencing buying pressure, which is a positive indicator for future bullish movement.
NEO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.26 | Sell |
Relative Strength Index (14 RSI): | 40.74 | Sell |
Chaikin Money Flow: | -1036382 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (7.13 - 7.77) | Sell |
Bollinger Bands (100): | (7.38 - 12.04) | Sell |
PBLA Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 43.66 | Sell |
Chaikin Money Flow: | 26822 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (0.24 - 0.28) | Sell |
Bollinger Bands (100): | (0.27 - 0.37) | Sell |
NEO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.31 | Sell |
20-day SMA: | 7.34 | Sell |
50-day SMA: | 8.08 | Sell |
200-day SMA: | 12.66 | Sell |
8-day EMA: | 7.19 | Sell |
20-day EMA: | 7.41 | Sell |
50-day EMA: | 8.16 | Sell |
200-day EMA: | 11.48 | Sell |
PBLA Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 0.25 | Sell |
20-day SMA: | 0.26 | Sell |
50-day SMA: | 0.28 | Sell |
200-day SMA: | 0.33 | Sell |
8-day EMA: | 0.25 | Sell |
20-day EMA: | 0.26 | Sell |
50-day EMA: | 0.28 | Sell |
200-day EMA: | 43.38 | Sell |
NeoGenomics Earnings Growth & NEO Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.04 per share, an increase next quarter of $0.03 per share, an increase this year of $0.06 per share, and an increase next year of $0.15 per share.
Panbela Therapeutics Earnings Growth & PBLA Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $4.71 per share, and an increase next year of $0.30 per share.
NeoGenomics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Panbela Therapeutics Technical Analysis
Jun 6 | Jun 9 | Jun 10 | Jun 11 | Jun 12 | Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |